Parkinson's disease is associated with a variety of dermatologic disorders and the study of
skin may provide insights into pathophysiological mechanisms underlying this common …

Bullous Pemphigoid is an autoimmune skin blistering disease. It is caused by deposition of
auto antibodies along the dermal-epidermal border leading to inflammation. The antibodies …

Introduction Rituximab (RTX) is a monoclonal antibody targeting CD20, a transmembrane
protein expressed on B cells, causing B cell depletion. RTX has shown great efficacy in …

Importance The role of bullous pemphigoid (BP) in cardiovascular disease (CVD) mortality
remains controversial, and analyses of causes of death among patients with BP based on …

Bullous pemphigoid (BP) is the most common autoimmune skin disease of blistering
character. The underlying pathophysiological mechanism involves an immune attack …

Importance The 1-year standardized mortality ratio (SMR) of bullous pemphigoid (BP) has
been reported as 2.15 to 7.56 and lower in the US than in Europe. Objective To estimate the …

Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder
in the elderly. Systemic and topical use of glucocorticoids and immunosuppressants has …

Background Nonbullous pemphigoid is an under-recognized phenotype of the autoimmune
bullous disease pemphigoid, characterized by the absence of blisters. Several disease …

Background. Bullous pemphigoid (BP) is the most common autoimmune bullous disease
associated with higher mortality and coexisting comorbidities. The strongest relationship has …

Objective To systematically evaluate the prognostic factors for mortality in bullous
pemphigoid. Methods PubMed, Embase, Cochrane Library, China National Knowledge …